VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WHWK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WHWKWhitehawk Therapeutics Inc
$4.02$199M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWHWKQuarterly Financials

Whitehawk Therapeutics Inc (WHWK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Whitehawk Therapeutics Inc (WHWK) quarterly income statement — complete revenue, gross profit & net income history

WHWK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue0007.14M7.24M7.21M6.18M5.35M6.33M5.96M6.2M5.87M5.23M4.25M3.44M2.31M1M000
Revenue Growth %-100%-100%-100%33.48%14.43%21.03%-0.37%-8.76%21.03%40.38%80.45%154.31%422.7%----92.86%---100%
Cost of Goods Sold05K0760K15.14M10.8M13.87M14.24M13.7M12.59M13.97M529K222K593K341K179K0000
COGS % of Revenue---10.64%209.1%149.76%224.49%266.11%216.49%211.23%225.27%9.02%4.25%13.97%9.92%7.76%----
Gross Profit0-5K06.38M-7.9M-3.59M-7.69M-8.89M-7.37M-6.63M-7.77M5.34M5M3.65M3.1M2.13M1M000
Gross Margin %---89.36%-109.1%-49.76%-124.49%-166.11%-116.49%-111.23%-125.27%90.98%95.75%86.03%90.08%92.24%100%---
Gross Profit Growth %100%99.86%100%171.81%-7.18%45.85%0.99%-266.58%-247.23%-281.49%-350.94%150.85%400.5%----92.86%--100%
Operating Expenses24.89M19.54M54.75M21.6M11.05M9.82M7.89M10.62M10.35M11.22M11.78M22.16M20.48M18.69M21.46M15.94M16.95M87.31M3.88M4.09M
OpEx % of Revenue---302.35%152.66%136.22%127.72%198.39%163.53%188.3%189.87%377.76%391.75%440.24%624.27%691.03%1694.5%---
Selling, General & Admin5.87M5.2M5.94M12.81M11.05M7.19M7.89M10.62M10.35M11.22M11.78M11.21M11.11M9.91M10.01M9.15M9.72M7.4M830K563K
SG&A % of Revenue---179.36%152.66%99.64%127.72%198.39%163.53%188.3%189.87%191.02%212.49%233.57%291.13%396.53%971.8%---
Research & Development19.02M14.35M48.81M8.79M14.35M10M13.09M13.59M12.77M11.89M13.31M10.96M9.37M8.77M7.73M6.79M7.23M5.75M3.04M3.64M
R&D % of Revenue---123%198.19%138.62%211.9%253.93%201.83%199.53%214.69%186.74%179.26%206.67%224.79%294.5%722.7%---
Other Operating Expenses0000-1000K-1000K-1000K-1000K-1000K-1000K-1000K0001000K001000K0-120K
Operating Income-24.89M-19.55M-54.75M-15.22M-18.95M-13.41M-15.58M-19.51M-17.71M-17.85M-19.55M-16.82M-15.47M-15.04M-18.36M-13.81M-15.95M-87.31M-3.88M-4.09M
Operating Margin %----212.99%-261.76%-185.98%-252.21%-364.51%-280.02%-299.53%-315.14%-286.77%-296%-354.2%-534.19%-598.79%-1594.5%---
Operating Income Growth %-31.34%-45.72%-251.32%22.01%-6.97%24.85%20.27%-15.97%-14.49%-18.71%-6.45%-21.8%2.97%82.78%-373.81%-238%-289.73%---27.59%
EBITDA-24.89M-19.54M-54.73M-15.17M-18.9M-13.37M-15.54M-19.46M-17.67M-17.8M-19.5M-16.79M-15.43M-15.02M-18.33M-13.74M-15.87M-87.28M-3.87M-4.08M
EBITDA Margin %----212.31%-261.11%-185.33%-251.42%-363.57%-279.32%-298.79%-314.45%-286.13%-295.12%-353.92%-533.4%-595.58%-1587.3%---
EBITDA Growth %-31.66%-46.2%-252.32%22.05%-6.97%24.93%20.34%-15.93%-14.55%-18.51%-6.38%-22.18%2.82%82.79%-373.35%-236.35%-288.83%---27.61%
D&A (Non-Cash Add-back)1K5K16K48.25K47K47K49K50K44K44K43K38K46K12K27K74K72K29K2K2K
EBIT-23.25M-17.75M-52.62M73.02M-18.27M-10.78M-14.53M-18.23M-16.21M-16.24M-17.91M-15.16M-13.87M-14.42M-18.2M-13.8M-15.93M-86.93M-1.31M-5.25M
Net Interest Income1.61M1.85M1.98M791K676K868K1M1.22M1.44M1.55M1.58M1.6M1.55M562K100K-43K-45K-157K-226K-224K
Interest Income1.61M1.85M1.98M791K676K906K1.06M1.28M1.5M1.6M1.64M1.66M1.61M620K158K15K12K01K0
Interest Expense0000038K58K58K57K58K58K58K57K58K58K58K57K157K227K224K
Other Income/Expense1.64M1.8M2.13M88.23M676K867K1M1.22M1.45M1.55M1.57M1.6M1.55M562K100K-43K-45K223K2.34M-1.39M
Pretax Income-23.25M-17.75M-52.62M73.02M-18.27M-12.55M-14.58M-18.29M-16.27M-16.3M-17.97M-15.22M-13.92M-14.47M-18.26M-13.86M-15.99M-87.09M-1.53M-5.48M
Pretax Margin %---1021.92%-252.42%-173.96%-236.01%-341.66%-257.18%-273.57%-289.76%-259.47%-266.35%-340.97%-531.28%-600.65%-1599%---
Income Tax000000000000-9K09K0002K0
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0.06%0%-0.05%0%0%0%-0.13%0%
Net Income-23.25M-17.75M-52.62M73.02M-18.27M-12.55M-14.58M-18.29M-16.27M-16.3M-17.97M-15.22M-13.91M-14.47M-18.27M-13.86M-15.99M-87.09M-1.54M-5.48M
Net Margin %---1021.92%-252.42%-173.96%-236.01%-341.66%-257.18%-273.57%-289.76%-259.47%-266.18%-340.97%-531.54%-600.65%-1599%---
Net Income Growth %-27.24%-41.45%-260.8%499.23%-12.32%23.04%18.85%-20.14%-16.93%-12.63%1.63%-9.86%12.99%83.38%-1089.39%-153.05%-299.38%---64.75%
Net Income (Continuing)-23.25M-17.75M-52.62M73.02M-18.27M-12.55M-14.58M-18.29M-16.27M-16.3M-17.97M-15.22M-13.91M-14.47M-18.27M-13.86M-15.99M-87.09M-1.54M-5.48M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.34-0.26-0.761.83-0.67-0.46-0.54-0.68-0.60-0.60-0.67-0.57-0.52-0.68-0.87-0.66-0.77-4.17-0.07-0.26
EPS Growth %49.25%43.48%-40.74%369.12%-11.67%23.33%19.4%-19.3%-15.38%11.76%22.99%13.64%32.47%83.69%-1080.46%-153.85%-237.5%--42.22%
EPS (Basic)-0.34-0.26-0.761.84-0.67-0.46-0.54-0.68-0.60-0.60-0.67-0.57-0.52-0.68-0.87-0.66-0.77-4.17-0.07-0.26
Diluted Shares Outstanding69.21M69.2M69.08M27.09M27.09M27.04M27.01M26.98M26.97M26.95M26.88M26.86M26.84M21.27M20.97M20.91M20.89M20.86M20.84M20.84M
Basic Shares Outstanding69.21M68.25M69.08M27.09M27.09M27.04M27.01M26.98M26.97M26.95M26.88M26.86M26.84M21.27M20.97M20.91M20.89M20.86M20.84M20.84M
Dividend Payout Ratio--------------------